Push to use big data in Japan gets help from industry, academia
14 May 2015
The pharmaceutical industry's producers and academic researchers in Japan are actively engaged, despite setbacks experienced by others such as Google ($GOOG), in building a big-data pipeline, this one now including 10 drugmakers and 30 medical institutions.
Supercooled nanoparticles offer targeted delivery approach
14 May 2015
The ability to supercool drug-carrying vesicles inside the body and time the exact moment of crystallization could lead to a targeted approach to drug delivery, researchers at Tel Aviv University have found.
China gears up to change the rules of the game on drug sales
14 May 2015
If China has its way, within another year or two, a repeat of the GlaxoSmithKline ($GSK) and similar scandals will be far less likely, but drugmakers can expect to face a harder sell as a result. The government just completed a comprehensive healthcare reform plan centered on the nation's public hospital system, but with a reach throughout the medical process.
Google signs on Harvard doc to lead bioinformatics study
14 May 2015
Google's Baseline study is getting a boost, with a Harvard cardiologist moving over to lead the initiative almost a year after the company revealed its plans to aggregate molecular and genetic data to jump-start medical research.
Big Pharma's cardiovascular sales ain't what they used to be
13 May 2015
Slumping sales for cardiovascular drugs isn't exactly a new phenomenon for Big Pharma, with some of the industry's top drugmakers suffering from recent patent expirations. But a new report shows which CV franchises have been hurt the most.
Rusnano launches Nuclear Medicine Centers Network
13 May 2015
Central Russia’s first Nuclear Medicine Centers Network has opened in the Lipetsk region. A sizable private-public partnership, the Network has the capacity to deliver y-tracers to neighboring regions, the Rusnano website announced. This $24+m effort is being pushed by PET-Technology, a portfolio company of Rusnano.
RPT-Under pressure, FDA to hold public meeting on off-label use
13 May 2015
The U.S. Food and Drug Administration will hold a public meeting this summer to address drug company concern that restrictions on what they can say about off-label use of drugs violate their First Amendment right to free speech.
Varian launches 'cloud community' to encourage information exchange among oncologists
13 May 2015
As the conversation shifts from collecting Big Data to what to do with it, Varian Medical Systems ($VAR) is focusing on efficient data sharing. The company hopes users of its just-launched OncoPeer platform will benefit from oncologists' collective intelligence by leveraging other practitioners' knowledge to the benefit of their own patients.
Building value via regional licensing; global dealmakers get guidance on Japan
12 May 2015
With international dealmaking often a key element of the biopharma asset development adventure, the path to success in Japan took center stage during the first day of Allicense, an annual pilgrimage for the industry's top business development pros.
Tiny drugmakers top list of most profitable, but Shire and Gilead are there, too
12 May 2015
Who are the most profitable companies in healthcare? Drug companies, with 7 out of 10 slots on a ranking by profit margin. Who are the most profitable drug companies? You might scratch your heads at all but a couple of names.
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
87% of cancer patients give positive ratings for medical care quality
18 September 2024
The Russian market of fillers and biorevitalizers grew by 21% in the first half of 2024
18 September 2024
Pharma’s Patient Reach Problem: Billions Still Left Behind
17 September 2024
17 September 2024